Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1999
12/23/1999CA2334797A1 Anthracene derivatives as anti-cancer agents
12/23/1999CA2334634A1 Novel benzopyran or thiobenzopyran derivatives
12/23/1999CA2334598A1 Vitamin b12 derivatives and methods for their preparation
12/23/1999CA2334369A1 Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders
12/23/1999CA2334254A1 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
12/23/1999CA2333666A1 Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
12/23/1999CA2333554A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
12/23/1999CA2333453A1 Methods for increasing levels of acetylcholine
12/23/1999CA2333384A1 Methods for reducing levels of homocysteine and c-reactive protein
12/23/1999CA2332997A1 A process for the treatment of organophosphate poisoning
12/23/1999CA2332325A1 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
12/23/1999CA2331382A1 Interaction of p27(kip1) with fkbp-12
12/23/1999CA2330667A1 Mycobacterial inhibitors
12/23/1999CA2329932A1 Composition for keeping away vermin
12/23/1999CA2301665A1 Methods and compositions for treatment of aids-associated kaposi's sarcoma
12/23/1999CA2300892A1 Methods of administering camptothecin compounds for the treatment of cancer with reduced side effects
12/23/1999CA2275558A1 Photochemical process
12/22/1999EP0965640A1 GP75 as a tumor vaccine for melanoma
12/22/1999EP0965591A1 (s)-3-methyl-1-(2-piperidino-phenyl)-1-butylamine, its salts, synthesis and use in the long term therapy of diabetes mellitus
12/22/1999EP0965587A1 Tetrahydropyridinyl- and piperidinyl Inhibitors of serotonin reuptake
12/22/1999EP0965583A1 Polyamine compounds and compositions containing them useful for the transfer of active substances into a cell
12/22/1999EP0965578A1 Novel triglyceride and composition comprising the same
12/22/1999EP0965351A2 Pharmaceutical composition for treating side-effects of a diet with reduced amount of carbohydrates
12/22/1999EP0965346A2 Use of acetylated mannan derivatives for treating chronic respiratory diseases
12/22/1999EP0965345A2 Use of acemannan
12/22/1999EP0965344A1 Prophylactic and therapeutic agent for inflammatory intestinal diseases
12/22/1999EP0965343A2 Ziprasidone formulations
12/22/1999EP0965342A1 Preparation for percutaneous administration
12/22/1999EP0965341A2 Combination of dofetilide and a calcium channel blocker
12/22/1999EP0965340A1 Dermatologic preparation
12/22/1999EP0965339A1 Tabletted preparation
12/22/1999EP0965338A1 Low oxygen content perfluoroalkanes for ophthalmologic use
12/22/1999EP0965336A1 Microencapsulated DNA for gene therapy
12/22/1999EP0965334A1 Liquid respiratory product for intubation
12/22/1999EP0965329A1 Skin treatment agents and use thereof for preparing dermatological compositions
12/22/1999EP0965327A1 Wrinkling modifiers
12/22/1999EP0965278A1 Dietetic food composition and dietetic method using such composition
12/22/1999EP0964930A1 Catalytic rna molecules
12/22/1999EP0964870A2 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
12/22/1999EP0964869A1 Methods and compositions for generating angiostatin
12/22/1999EP0964865A2 Pharmaceutically active tricyclic amines
12/22/1999EP0964864A2 Pyrido 2,3-d] pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation
12/22/1999EP0964863A1 Oxazolidines as 5-ht2a-antagonists
12/22/1999EP0964861A1 Process for the production of tetrazolylbenzopyrans
12/22/1999EP0964860A1 Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions
12/22/1999EP0964859A1 New process
12/22/1999EP0964856A1 Bicyclic amino acids
12/22/1999EP0964854A1 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-thiones derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists
12/22/1999EP0964853A1 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists
12/22/1999EP0964852A1 Indolecarboxylic compounds and their use as pharmaceutical compounds
12/22/1999EP0964851A1 C-terminal ketone hydroxamic acid inhibitors of matrix metalloproteinases and tnfa secretion
12/22/1999EP0964849A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
12/22/1999EP0964694A1 Mucin-mediated immunomodulation
12/22/1999EP0964687A1 Pharmaceutical compositions with antimicrobial activity
12/22/1999EP0964686A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions
12/22/1999EP0964685A1 Composition and method for treating fungal disease in animals
12/22/1999EP0964684A1 Crystalline pharmaceutical product
12/22/1999EP0964683A1 Leukotriene antagonists for oral squamous cell carcinoma
12/22/1999EP0964682A1 A method of treating liver disease and like indications with vasodilating agents
12/22/1999EP0964681A2 Anticonvulsant derivatives useful in treating psoriasis
12/22/1999EP0964680A1 Use of nitric oxide inhibitors for treating side effects of particulate drugs
12/22/1999EP0964679A1 Method for the treatment of neurological or neuropsychiatric disorders
12/22/1999EP0964678A1 Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions
12/22/1999EP0964677A1 Sustained analgesia achieved with buprenorphine
12/22/1999EP0964676A1 Microparticles and their use in cancer treatment
12/22/1999EP0939628A4 Thiol sulfone metalloprotease inhibitors
12/22/1999EP0923382A4 Compositions of plant carbohydrates as dietary supplements
12/22/1999EP0910385A4 Sensitization of cells to radiation and chemotherapy
12/22/1999EP0910362A4 Oxa acids and related compounds for treating skin conditions
12/22/1999EP0904077A4 Methods for the preparation of biphenyl isoxazole sulfonamides
12/22/1999EP0876160B1 Ligand directed enzyme prodrug therapy
12/22/1999EP0839148B1 (r)-(z)-1-azabicyclo 2.2.1]heptan-3-one,o- 3-(3-methoxyphenyl)-2-propynyl]oxime maleate as a pharmaceutical agent
12/22/1999EP0758312B1 Substituted fused and bridged bicyclic compounds as therapeutic agents
12/22/1999EP0757560B1 Ophthalmic compositions comprising amidoamines
12/22/1999EP0748228A4 Method and device for the provocation of air passage narrowing and/or the induction of sputum
12/22/1999EP0733033B1 Pharmaceutically active substituted aromatic compounds
12/22/1999EP0731795B1 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
12/22/1999EP0726893B1 Novel 4-piperidinyl substituted lactames as neurokinin 2 receptor antagonists for the treatment of asthma
12/22/1999EP0711167A4 Methods of enhancing opiate analgesic potency or detoxifying an opiate addict
12/22/1999EP0684953A4 Adenosine kinase inhibitors comprising lyxofuranosyl derivatives.
12/22/1999EP0674628B1 Chemopreventive compounds and a preparation method and use thereof
12/22/1999EP0668785B1 System and method for providing a sterile medical solution containing glucose or and glucose-like compounds
12/22/1999EP0661973A4 Method of preventing nmda receptor complex-mediated neuronal damage.
12/22/1999EP0659083B1 Prevention and treatment of peripheral neuropathy
12/22/1999EP0635018B1 4-(1H-2-METHYLIMIDAZO[4,5-c]PYRIDINYLMETHYL)PHENYLSULPHONAMIDE DERIVATIVES AS ANTAGONISTS OF PAF
12/22/1999EP0609394B1 Anti-explosion pads and their method of use
12/22/1999EP0515386B1 Glycoalkaloids
12/22/1999CN1239474A Substituted pyridines and biphenyls as anti-hypercholesterinemic, anti-hyperlipoproteinemic and anti-hyperglycemic agents
12/22/1999CN1239436A Topical prepn. for introducing peptidaceous pharmacons in living organisms
12/22/1999CN1239435A Methods and compsns. for stimulating neurite growth using compounds with affinity for FKBP12 in combination with neurotrophic factors
12/22/1999CN1239434A Methods and compsns. for stimulating neurite growth using compounds with affinity for FKBP12 in combination with neurotrophic factors
12/22/1999CN1239433A Methods and compsns. for stimulating neurite growth using compounds with affinity for PKBP12 in combination with neurotrophic factors
12/22/1999CN1239430A Treatment of highly vascular tumours
12/22/1999CN1239429A Methods for minimizing bone loss
12/22/1999CN1239427A Use of mupirocin for manufacture of medicament for treatment of bacterial infections associated with colonisation of nasopharynx by pathogenic organisms
12/22/1999CN1239097A Artemisine compounds, their preparing process and medicine composition containing them
12/22/1999CN1238953A Notoginseng medicine for oral application
12/22/1999CN1238951A Nafiverine injection
12/22/1999CN1238950A Compound antimalarial medicine containing artemisine medicines and malaridine
12/22/1999CN1238948A Making dosage units using low shear granulation
1 ... 6391 6392 6393 6394 6395 6396 6397 6398 6399 6400 6401 6402 6403 6404 6405 6406 6407 6408 6409 6410 6411 ... 7860